Human Papilloma Virus and Squamous Cell Carcinoma of the Anus
[Clin Med Insights Oncol] HPV is a risk factor for anal intraepithelial neoplasia (AIN). Etiology, anatomy, pathogenesis, management of squamous cell carcinoma (SCC) discussed.
[Clin Med Insights Oncol] HPV is a risk factor for anal intraepithelial neoplasia (AIN). Etiology, anatomy, pathogenesis, management of squamous cell carcinoma (SCC) discussed.
Research suggests the human papillomavirus (HPV) vaccine could prevent 90 percent of cervical malignancies.
Less invasive method may increase screening rates for cervical cancer, researchers say.
A review of data suggests that HPV testing alone every 3 years provides a high level of reassurance against cervical cancer.
Registry data show increase in incidence rates of HPV-related oropharyngeal and anal cancers.
Risk for venous thromboembolism appears to be no higher after quadrivalent HPV vaccination.
For patients with oropharynx cancer, HPV positivity is associated with improved survival after disease progression.
A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects. The research was presented by lead author Anthony Cmelak, MD, professor of Radiation Oncology at Vanderbilt-Ingram Cancer Center, during the 50th annual meeting of the American Society ofkeep…
HPV test can detect 95% of precancerous lesions, and cotesting with Pap detects more disease.
Two-thirds of surveyed adults reported being not very or not at all knowledgeable about head and neck cancer.